Concepedia

Carlotta Antoniotti

CA

75

Publications

6.6K

Citations

32

H-Index

1993

Active since

Affiliations

Azienda Ospedaliera Universitaria Pisana(Current)

University of Pisa

Istituto Oncologico Veneto

Istituti di Ricovero e Cura a Carattere Scientifico

Fondazione IRCCS Istituto Nazionale dei Tumori

Carlotta Antoniotti is an author at Azienda Ospedaliera Universitaria Pisana specializing in medicine, colorectal cancer, and oncology.

ORCID

Top concepts

Publications per year

1993–2025

75

Publications

75

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

Giulia Siravegna, Benedetta Mussolin, Michela Buscarino et al. · Nature Medicine · 2015 · 1.1K citations · Full text

, , +6

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti et al. · The Lancet Oncology · 2015 · 1.1K citations · Full text

, , +8

Primary Tumor Location as a Prognostic Factor in Metastatic Colorectal Cancer

Fotios Loupakis, Dongyun Yang, Linda Yau et al. · JNCI Journal of the National Cancer Institute · 2015 · 489 citations · Full text

ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal Cancer

Filippo Pietrantonio, Federica Di Nicolantonio, Alexa B. Schrock et al. · JNCI Journal of the National Cancer Institute · 2017 · 322 citations · Full text

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Giovanni Fucà, Vincenzo Guarini, Carlotta Antoniotti et al. · British Journal of Cancer · 2020 · 315 citations · Full text

Rows per page

1–5 of 75